METOPROLOL TARTRATE Drug Patent Profile
✉ Email this page to a colleague
When do Metoprolol Tartrate patents expire, and when can generic versions of Metoprolol Tartrate launch?
Metoprolol Tartrate is a drug marketed by Am Regent, Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hikma Farmaceutica, Hospira, Luitpold, Sandoz, Steriscience Speclts, Watson Labs, Alembic Pharms Ltd, Apothecon, Aurobindo Pharma, Chartwell Rx, Heritage Pharma, Ipca Labs Ltd, Mylan, Norvium Bioscience, Purepac Pharm, Renata, Rubicon, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Youngtech Pharms Inc, Zydus Pharms, Alembic, and Sun Pharm Inds. and is included in thirty-six NDAs.
The generic ingredient in METOPROLOL TARTRATE is hydrochlorothiazide; metoprolol tartrate. There are thirty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METOPROLOL TARTRATE?
- What are the global sales for METOPROLOL TARTRATE?
- What is Average Wholesale Price for METOPROLOL TARTRATE?
Summary for METOPROLOL TARTRATE
See drug prices for METOPROLOL TARTRATE
Recent Clinical Trials for METOPROLOL TARTRATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Consorcio Centro de Investigación Biomédica en Red (CIBER) | Phase 3 |
| Instituto de Salud Carlos III | Phase 3 |
| European Commission | Phase 3 |
Pharmacology for METOPROLOL TARTRATE
| Drug Class | beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for METOPROLOL TARTRATE
US Patents and Regulatory Information for METOPROLOL TARTRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; metoprolol tartrate | TABLET;ORAL | 090654-002 | Jan 19, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Renata | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 074453-002 | Apr 27, 1995 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 076704-004 | Mar 18, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm Inds Inc | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 074644-002 | Dec 10, 1996 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Youngtech Pharms Inc | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 208955-002 | Feb 5, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
